Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
5,045,065
-
Shares change
-
+1,651,969
-
Total reported value, excl. options
-
$13,568,683
-
Value change
-
+$4,343,192
-
Number of buys
-
23
-
Number of sells
-
21
-
Price
-
$2.69
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q1 2017
As of 31 Mar 2017 Niagen Bioscience, Inc. - Common Stock (NAGE) had 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,045,065 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Tieton Capital Management, LLC, STATE STREET CORP, NORTHERN TRUST CORP, Granite Investment Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, North Star Investment Management Corp., and TIAA CREF INVESTMENT MANAGEMENT LLC.
This table shows 55 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.